Table 3. Changes in Volumetric Functional Metrics and Anatomic Metrics.
Parameter | Before Treatment | After Treatment | Median Percentage Change | P Value* |
---|---|---|---|---|
Anatomic metric | ||||
RECIST | 7.9 cm ± 4.4 | 7.4 cm ± 4.4 | −8.6 | <.002 |
mRECIST | 6.5 cm ± 3.7 | 5.2 cm ± 3.7 | −18.2 | <.0001 |
EASL | 42.2% ± 47.1 | 25.8% ± 39.1 | −47.9 | <.0001 |
Volumetric functional metric | ||||
Volumetric ADC | 1.24 × 10−3 mm/sec2 ± 0.313 | 1.55 × 10−3 mm/sec2 ± 0.417 | 20.3 | <.0001 |
Volumetric arterial enhancement | 54.2% ± 42.3 | 31.5% ± 32.6 | −33.2 | <.0001 |
Volumetric venous enhancement | 82.5% ± 31.2 | 60.4% ± 33.7 | −16.7 | <.0001 |
Note.—Unless otherwise indicated, data are means ± standard deviations. There were significant changes in tumor size according to RECIST and enhancement according to EASL and mRECIST, but their median percentage change did not fulfill the partial response according to respective criteria.
P value indicates changes in pretreatment and 3–4-week posttreatment data analyzed by using a paired Student t test.